Dexbrompheniramine
Dexbrompheniramine is an orally active H1 receptor antagonist. Dexbrompheniramine is an antihistamine that reduces the effects of natural chemical histamine. Dexbrompheniramine can be used for the research of hay fever and urticaria[1].
Product Specifications
CAS Number
[132-21-8]
Product Name Alternative
(+) -Brompheniramine; (S) -Brompheniramine
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Endogenous Metabolite; Histamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dexbrompheniramine.html
Purity
99.60
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
CN(C)CC[C@H](C1=CC=CC=N1)C2=CC=C(C=C2)Br
Molecular Formula
C16H19BrN2
Molecular Weight
319.24
Precautions
H315, H319, H320
References & Citations
[1]Rossi R, et, al. Effects of histamine H1 receptors on the feeding and drinking patterns in pygmy goats. J Dairy Sci. 1998 Sep;81 (9) :2369-75.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
H1 Receptor
Available Sizes
Explore Other Products
Browse additional items from our catalog
RPS27P15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
FRS2 (Fibroblast growth factor receptor substrate 2, FGFR substrate 2, FGFR-signaling adaptor SNT, Suc1-associated neurotrophic factor target 1, SNT-1)
FRS2 (Fibroblast growth factor receptor substrate 2, FGFR substrate 2, FGFR-signaling adaptor SNT, Suc1-associated neurotrophic factor target 1, SNT-1)